Project Grant 1L1CMS331458

This Project Grant award of $1,200,000 from the U.S. Department of Health and Human Services' Office of Minority Health under the Community Programs to Improve Minority Health (CFDA 93.137) program aims to implement community-level innovations to improve diabetes health outcomes among the Hispanic/Latino population in Bexar County, Texas. The "Pathways Project" will expand a sustainable collaborative network, including organizations like The Health Collaborative and Community...

This federal Project Grant award from the National Center for Advancing Translational Sciences (NCATS), CFDA #93.350, aims to develop a consensus-driven measurement strategy for assessing cognitive function in patients with thrombotic thrombocytopenic purpura (TTP), a rare and life-threatening blood disorder. The $456,348 award to Duke University, scheduled to be completed by July 31, 2026, will fund a study to determine the impacts of TTP on cognitive function and establish a rigorous...

The National Center for Advancing Translational Sciences (NCATS) awarded a $456,728 Project Grant to Case Western Reserve University (CWRU) to support the Clinical and Translational Science Collaborative of Northern Ohio's Predoctoral T32 Program (CTSTP-PRE). The grant, which runs from July 2025 through June 2030, will fund the training of doctoral students across several Ph.D. programs focused on clinical and translational research. The program aims to equip trainees with transdisciplinary...

This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) aims to integrate a pharmacy technician-based model for delivering long-acting injectable cabotegravir-rilpivirine (LA-CAB/RPV) into community-based Federally Qualified Health Centers (FQHCs) that serve underserved people with HIV. The $1.2M award to the University of Chicago will fund a 5-year study to adapt and test this model in 5 FQHC clinics in Chicago,...

This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $289,620 to Oregon State University to develop a personalized therapeutic drug monitoring (PTDM) system. The key products and services to be delivered under this 4-year project include: A personalized drug titration pharmacokinetic (PK) model to account for varying drug...

This $2,663,022 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a 5-year study to test the effectiveness, implementation, and cost of Cognitive Processing Therapy adapted for delivery in criminal justice settings (CPT-CJ) as an intervention to reduce post-incarceration drug use, mental health symptoms, and drug-related crime among justice-involved individuals with substance use disorders and trauma...

The National Center for Advancing Translational Sciences (NCATS), a part of the National Institutes of Health, awarded a $3,024,414 Project Grant (CFDA 93.350) to Phrase Health, Inc. to establish a library of "out of the box" quality improvement (QI) templates for clinical decision support (CDS) systems. The funding will enable Phrase Health to develop QI templates for the inpatient management of diseases included in the Hospital Readmissions Reduction Program, such as pneumonia,...

This $512,812 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a pilot randomized trial to test the feasibility and preliminary efficacy of the T1CARE intervention. T1CARE aims to address social determinants of health for young adults with type 1 diabetes through comprehensive assessment, responsiveness, and engagement. The study will partner with a community-based...

The National Institute of Nursing Research (NINR), under the Nursing Research Federal Grant Program (CFDA 93.361), awarded a $1,606,442 Project Grant to Duke University to conduct a cluster randomized controlled trial of the "Using PREP, Doing It For Ourselves (UPDOS) Protective Styles" intervention. This e-health intervention aims to improve PrEP (pre-exposure prophylaxis) uptake among Black cisgender women in the southern United States, who have been disproportionately affected by...

This Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA), under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, will provide $1,479,058 to Wake Forest University Health Sciences to operate the Southeast Prevention Technology Transfer Center (SE PTTC) for Region 4, which includes Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee. The SE...